| Financial Year |
March 31 2023 |
| Monetary Funds |
3,235,498,220.20 |
| Held-for-trading Financial Assets |
2,100,000.00 |
| Notes Receivable |
729,920,854.41 |
| Accounts Receivable |
1,654,397,108.79 |
| Advances to Suppliers |
1,485,748,004.78 |
| Other Receivables |
44,272,305.32 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
34,729.50 |
| Inventories |
2,255,280,639.37 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
295,294,401.64 |
| Total Current Assets |
11,242,507,265.34 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
195,849,627.67 |
| Investment Properties |
91,728,667.10 |
| Fixed Assetes |
6,682,926,110.25 |
| Under-construction Projects |
1,233,737,159.20 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
462,434,885.44 |
| R&D expenses |
4,347,007.03 |
| Goodwill |
285,113,345.03 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
224,011,607.76 |
| Other Non-Current Assets |
89,049,358.11 |
| Sub-Total of Non-Current Assets |
9,317,938,684.98 |
| Total Assets |
20,560,445,950.32 |
| Short-Term Loans |
150,700,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
160,627,554.31 |
| Accounts Payable |
1,789,795,687.42 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
177,655,188.29 |
| Taxes Payable |
155,837,068.74 |
| Interest Payable |
1,974,929.77 |
| Dividend Payable |
44,441,960.89 |
| Other payables |
373,469,045.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,121,718,848.13 |
| Other Current Liabilities |
342,628,807.02 |
| Sub-Total of Current Liabilities |
6,980,672,000.50 |
| Long-term Loans |
2,329,681,275.48 |
| Bonds Payable |
1,050,644,555.19 |
| Long-Term Accounts Payable |
668,400.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
4,024,640.00 |
| Deferred Income Tax Liabilities |
843,908.17 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,679,033,545.20 |
| Total Liabilities |
10,659,705,545.70 |
| Paid-In Capital(Or Share Stock) |
984,542,600.00 |
| Capital Surplus |
2,335,885,456.41 |
| Surplus Reserve |
600,196,402.12 |
| LESS:Treasury Stock |
258,494,700.00 |
| Undistributed Profits |
4,916,175,866.13 |
| Minority Stockholder's Interest |
1,060,257,082.09 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,840,483,322.53 |
| Owner's Equity（Stockholder's Equity） |
9,900,740,404.62 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
20,560,445,950.32 |
